Sackett D. How to read clinical journals: I. why to read them and how to start reading them critically. Can Med Assoc J. 1981;124(5):555–8.
Guyatt G. Evidence-based medicine. Ann Intern Med. 1991;14(2):A-16–23.
Rosenberg W, Donald A. Evidence based medicine: an approach to clinical problem-solving. BMJ (Clin Res Ed). 1995;310:1122–6.
Favaloro RG. Saphenous vein autograft replacement of severe segmental coronary artery occlusion: operative technique. Ann Thorac Surg. 1968;5:334–9.
Gruentzig AR. Percutaneous transluminal coronary angioplasty. Semin Roentgenol. 1981;16:152–3.
Takaro T, Hultgren HN, Lipton MJ, Detre KM. The VA cooperative randomized study of surgery for coronary arterial occlusive disease II. Subgroup with significant left main lesions. Circ. 1976;54:III107–17.
Fisher L, CASS Principal Investigators and their Associates. Coronary Artery Surgery Study (CASS): a randomized trial of coronary artery bypass surgery: survival data. Circ. 1983;68:939–50.
Yusuf S, Zucker D, Chalmers TC. Ten-year results of the randomized controlled trials of coronary artery bypass graft surgery: tabular data compiled by the collaborative effort of the original trial investigators: Part 2 of 2. The Online Journal of Current Clinical Trials. Lancet. 1994;344:1446–58.
Parisi AF, Folland ED, Hartigan P, et al. A comparison of angioplasty with medical therapy in the treatment of single-vessel coronary artery disease. Veterans Affairs ACME Investigators. N Engl J Med. 1992;326:10–6.
RITA-2 Study Group. Coronary angioplasty versus medical therapy for angina: the second Randomised Intervention Treatment of Angina (RITA-2) trial. RITA-2 trial participants. Lancet. 1997, 350:461–8.
Boden WE, O’Rourke RA, Teo KK, et al. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med. 2007;356:1503–16.
The BARI 2D Study Group. A randomized trial of therapies for type 2 diabetes and coronary artery disease. N Engl J Med. 2009;360:2503–15.
De Bruyne B, Pijls NHJ, Kalesan B, et al. Fractional flow reserve–guided PCI versus medical therapy in stable coronary disease. N Engl J Med. 2012;367:991–1001.
De Bruyne B, Fearon WF, Pijls NHJ, et al. Fractional flow reserve–guided PCI for stable coronary artery disease. N Engl J Med. 2014;371:1208–17.
Xaplanteris P, Fournier S, NHJ P, Fearon WF, Barbato E, PAL T, et al. Five-year outcomes with PCI guided by fractional flow reserve. N Engl J Med. 2018;379:250–9.
Maron DJ, Hochman JS, Reynolds HR, Bangalore S, O’Brien SM, Boden WE. Initial invasive or conservative strategy for stable coronary disease. N Engl J Med. 2020;382:1395–407.
Spertus JA, Jones PG, Maron DJ, O'Brien SM, Reynolds HR, Rosenberg Y, et al. Health-status outcomes with invasive or conservative care in coronary disease. N Engl J Med. 2020;382:1408–19.
Weintraub WS, Spertus JA, Kolm P, Maron DJ, Zhang Z, Jurkovitz C, et al. Effect of PCI on quality of life in patients with stable coronary disease. N Engl J Med. 2008;359:677–87.
Hachamovitch R, Rozanski A, Shaw LJ, Stone GW, Thomson LEJ, Friedman JD. Impact of ischaemia and scar on the therapeutic benefit derived from myocardial revascularization vs. medical therapy among patients undergoing stress-rest myocardial perfusion scintigraphy. Eur Heart J. 2011;32:1012–24.
Hachamovitch R, Hayes SW, Friedman JD, Cohen I, Berman DS. Comparison of the short-term survival benefit associated with revascularization compared with medical therapy in patients with no prior coronary artery disease undergoing stress myocardial perfusion single photon emission computed tomography. Circ. 2003;107:2900–7.
Stergiopoulos K, Boden WE, Hartigan P, Möbius-Winkler S, Hambrecht R, Hueb W. Percutaneous coronary intervention outcomes in patients with stable obstructive coronary artery disease and myocardial ischemia: a collaborative meta-analysis of contemporary randomized clinical trials. JAMA Intern Med. 2014;174:232–40.
Al-Lamee R, Thompson D, Dehbi H-M, et al. Percutaneous coronary intervention in stable angina (ORBITA): a double-blind, randomised controlled trial. Lancet. 2018;391:31–40.
留言 (0)